Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PTGER2 contributors: mct/npt - updated : 22-03-2010
HGNC name prostaglandin E receptor 2 (subtype EP2), 53kDa
HGNC id 9594
EXPRESSION
Type restricted
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveliver    
Lymphoid/Immunespleen    
 thymus    
Respiratorylung    
Urinarykidney    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow   
Connectivecartilage  highly
cells
SystemCellPubmedSpeciesStageRna symbol
Blood/Hematopoieticleukocyte
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period pregnancy
Text placenta
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • seven transmembrane segments (7TM) receptor
  • HOMOLOGY
    Homologene
    FAMILY
  • G-protein coupled receptor 1 family
  • CATEGORY receptor membrane G
    SUBCELLULAR LOCALIZATION     plasma membrane
    basic FUNCTION
  • PGE2/ PTGER2 complex may regulate neoplastic cell function in cervical carcinoma in an autocrine/paracrine manner
  • promotes the growth of articular chondrocytes
  • PTGER2 receptor-cAMP signalling pathway implicated in the stimulation of progesterone production and 11betaHSD1 activity by prostaglandin E(2) in granulosa-lutein cells (Chandras 2007)
  • directs prostaglandin E2-mediated fibroblast responses via regulation of PTGER2 expression (Sagana 2009)
  • potential roles of inflammatory reaction by PTGER2 upregulation in carcinogenic process to microsatellite instability-high colorectal cancer (Baba 2010)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    Other regulatrd by PTEN (PTEN directly regulates Prostaglandin E(2) inhibition of fibroblast activation by augmenting PTGER2 expression) (Sagana 2009)
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    by epigenetic silencing is associated with progression of neuroblastomas (Sugino 2007)
    tumoral     --over  
    associated with worse prognosis, and correlated positively with tumor invasion status in esophageal squamous cell carcinoma (Kuo 2009)
    tumoral     --low  
    by aberrant methylation of the PTGER2 gene observed frequently in nonsmall cell lung cancer tissues and associated with the presence of EGFR mutation and a better prognosis (Tian 2008)
    Susceptibility to aspirin-intolerant asthma (AIA)
    Variant & Polymorphism SNP SNP associated with the susceptibility to AIA
    Candidate gene
    Marker
    Therapy target PTGER2 agonist is a candidate for a new therapeutic compound for the treatment of degenerative cartilage diseases
    ANIMAL & CELL MODELS